Over the past four decades, global rates of overweight and obesity have risen sharply, prompting questions about the underlying drivers of this trend. While genetics, hormones, and lifestyle factors such as physical activity clearly play a role, one environmental change stands out: the dramatic rise in ultra-processed foods (UPFs). Today, UPFs – ranging from ready meals and sugary snacks to fizzy drinks – make up a significant portion of daily diets worldwide.

In the UK, UPFs are increasingly recognised for their potential to trigger addictive-like eating behaviours, raising important considerations for public health and regulatory oversight. These foods are engineered not only for convenience but also to exploit brain reward pathways, amplifying concerns among health professionals and researchers.

The Science Behind Engineered Palatability

UPFs are deliberately designed to be hyper-palatable, combining high levels of sugar, salt, fat, and artificial additives to create an intense sensory experience. This composition stimulates the mesolimbic dopamine system, the same neural pathway involved in substance addiction. Consequently, consuming UPFs can lead to compulsive eating patterns, cravings, and difficulty controlling intake.

Recent research further demonstrates that UPFs:

  • Activate brain-gut-microbiome pathways, suggesting complex physiological responses beyond the central nervous system.
  • Can trigger withdrawal-like symptoms in some individuals when intake is reduced.
  • Meet criteria comparable to other addictive substances, highlighting the depth of their behavioural impact.

Recent Findings and Emerging Concerns

Significant developments in the field of UPF addiction have emerged over the last few years:

  • Prevalence: Global estimates indicate that around 14% of adults and 15% of youths meet criteria for UPF addiction.
  • Health disparities: Rates are higher among persons of colour and those experiencing food insecurity, revealing socio-economic and environmental inequities in exposure and vulnerability.
  • Weight management implications: Individuals with UPF addiction often experience poorer outcomes in weight control and dietary interventions, underscoring the need for tailored strategies.

These findings illustrate the growing recognition of UPF addiction as a legitimate public health concern, with implications for both policy and clinical practice.

Clinical Evidence and Regulatory Guidance

High UPF consumption is linked to increased calorie intake, higher body weight, and a greater risk of chronic diet-related conditions. Functional imaging studies show that UPFs activate brain reward circuits similarly to addictive substances, supporting the biological basis of these behaviours.

In the UK, public health authorities including the Scientific Advisory Committee on Nutrition (SACN) and NHS guidance emphasise the importance of limiting highly processed foods to support overall health and prevent chronic disease. Regulatory considerations extend to marketing restrictions, product labelling, and public health campaigns targeting high-risk groups.

Public Health and Policy Implications

The widespread availability and consumption of UPFs create challenges across multiple sectors. Key regulatory and public health considerations include:

  • Education: Raising awareness of UPF addiction and promoting informed dietary choices.
  • Support and intervention: Developing targeted programmes for individuals struggling with compulsive eating linked to UPFs.
  • Regulatory measures: Limiting marketing to vulnerable populations, improving transparency in labelling, and ensuring compliance with nutrient standards.

Addressing UPF addiction requires a coordinated approach between regulators, healthcare providers, and industry stakeholders, with the goal of reducing diet-related harm while promoting healthier eating behaviours.

Conclusion

Ultra-processed foods are more than a dietary convenience—they are engineered to influence behaviour in ways that can foster addiction-like eating patterns. Recent scientific evidence highlights:

  • Prevalence and disparities in affected populations
  • Biological mechanisms including brain-gut-microbiome interactions
  • Challenges in weight management for those with UPF addiction.

For regulatory and public health professionals, recognising these factors is essential to guide policy development, interventions, and consumer protection strategies. Leasing insights from ongoing research and implementing evidence-based interventions can help mitigate the impact of UPFs on public health, particularly among vulnerable populations.

Back to News + Insights